Mizuho initiated coverage on Patterson Companies with a new price target
$PDCO
Medical Specialities
Health Care
Mizuho initiated coverage of Patterson Companies with a rating of Neutral and set a new price target of $23.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/4/2024 | $23.00 | Neutral | Mizuho |
| 2/29/2024 | $34.00 → $28.00 | Overweight → Neutral | Piper Sandler |
| 2/26/2024 | $36.00 | Outperform | Leerink Partners |
| 5/13/2022 | $36.00 | Outperform | Credit Suisse |
| 3/3/2022 | $30.00 → $32.00 | Equal-Weight | Morgan Stanley |
| 1/31/2022 | $30.00 | Equal-Weight | Morgan Stanley |
| 10/1/2021 | $38.00 | Outperform | Credit Suisse |
15-12G - PATTERSON COMPANIES, INC. (0000891024) (Filer)
8-K - PATTERSON COMPANIES, INC. (0000891024) (Filer)
S-8 POS - PATTERSON COMPANIES, INC. (0000891024) (Filer)
NEW YORK, April 14, 2025 /PRNewswire/ -- Sterling Infrastructure Inc. (NASD: STRL) will replace Patterson Companies Inc. (NASD: PDCO) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, April 17. Patient Square Capital is acquiring Patterson Companies in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 17, 2025 S&P SmallCap 600 Addition Sterling Infrastructure STRL Industrials April 17, 2025 S&P SmallCap 600 Deletion Patterson Companies PDCO Health Care Fo
Patterson Companies, Inc. (NASDAQ:PDCO), a value-added specialty distributor serving the U.S. and Canadian dental supply markets and the U.S., Canadian and U.K. animal health supply markets, today announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital, a dedicated health care investment firm. Don Zurbay, Patterson's President and Chief Executive Officer, said, "I would like to express my gratitude to the Patterson shareholders for their support today, and throughout this transaction process. The Patterson team is excited about this partnership with Patient Square Capital and beginning our next chapter as a private company. We be
Third quarter reported net sales decreased 2.7 percent year-over-year to $1.57 billion, and internal sales decreased 2.4 percent. Delivered third quarter GAAP earnings of $0.35 per diluted share and adjusted earnings1 of $0.43 per diluted share; both GAAP and adjusted earnings1 were negatively impacted by the cybersecurity attack on Change Healthcare compared to the prior year. Returned $119.2 million to shareholders in the form of cash dividends and share repurchases through the first nine months of fiscal 2025. Patterson Companies, Inc. (NASDAQ:PDCO) today reported operating results for its fiscal 2025 third quarter ended January 25, 2025. "As we continue to progress toward cl